Serum GFAP Dynamics, Disease Progression, and Therapy Response in MS

Дата публикации: 03-08-2026 00:00:00

This cohort study evaluates the association between serum glial fibrillary acidic protein levels and future progression of multiple sclerosis.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis	0	8.77	01-04-2024
2	Multiple Sclerosis Onset Preceding Epstein-Barr Virus Infection	0	12.53	03-08-2026
3	Teriflunomide and Time to Clinical Multiple Sclerosis in Radiologically Isolated Syndrome	0	6.92	01-10-2023
4	Tau Oligomer–Containing Synapses Engulfed by Microglia and Astrocytes in Alzheimer Disease	0	7.6	01-11-2023
5	Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment	0	14.88	14-07-2026
6	Cognitive Outcomes After Catheter Ablation for Atrial Fibrillation	0	8.06	31-07-2026
7	Cessation of Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis—Clinical Trial of the Year	0	9.74	15-07-2026
8	These fat-filled brain cells may be making multiple sclerosis worse	0	7.88	29-06-2026
9	Diverse Research Teams and Underrepresented Groups in Clinical Studies	0	6.4	01-11-2023
10	Gefurulimab and Generalized Myasthenia Gravis	0	10.42	27-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.04. Источник: jamanetwork.com.